ICD-10-CM Billable Code

T43.225

Adverse effect of selective serotonin reuptake inhibitors

Clinical Classification Guidelines

Medical Intelligence & Overview

Selective serotonin reuptake inhibitors (SSRIs) are a class of medications commonly prescribed to treat depression, anxiety, and other mental health conditions. While generally effective and well-tolerated, SSRIs can sometimes cause adverse effects. The ICD-10 code T43.225 specifically refers to adverse effects associated with these medications. Recognizing these effects can aid in managing and addressing any concerns that may arise during treatment.

Causes & Symptoms

Clinical Causes: Sensitivity or allergic reaction to the medication Incorrect dosage or prolonged use Interaction with other medications or substances Underlying health conditions affecting drug metabolism Individual differences in how bodies process medication

Key Symptoms: Gastrointestinal issues such as nausea, diarrhea, or stomach upset Sleep disturbances, including insomnia or drowsiness Increased anxiety or agitation Changes in sexual desire or function Headaches or dizziness Sweating or flushing Weight changes Rash or allergic skin reactions Serotonin syndrome symptoms such as confusion, hallucinations, or rapid heartbeat (rare but serious)

Diagnostic & Treatment

Diagnosis Path: Diagnosing adverse effects of SSRIs involves a healthcare professional reviewing the patient's medication history, symptoms, and overall health. They may perform physical examinations and recommend tests to rule out other causes or complications. It is important to distinguish side effects caused by the medication from symptoms related to other medical conditions or mental health disorders.

Treatment Protocols: Managing adverse effects typically includes adjusting the dosage, switching to an alternative medication, or discontinuing the SSRI under medical supervision. Supportive treatments like symptom-specific medications or therapies may be recommended. Monitoring is essential to ensure adverse effects are minimized and the patient's overall health is maintained during treatment.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T43.225 a billable ICD-10 code?
Yes, T43.225 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T43.225?
Clinical documentation must specify the nature of Adverse effect of selective serotonin reuptake inhibitors and any associated comorbidities for accurate reporting.

Cite this Clinical Reference